Bellicum Pharmaceuticals

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.

Select Venture Capital & Financial Partners

Aisling Capital BioVeda Capital CDIB Ventures D.E. Shaw GeneChem Therapeutics HBM BioVentures Lombard Odier & Cie Nomura International Novartis Venture Fund Pacific Growth Equities POD Holding Schweizerhall Holding AG Wheatley Partners
www.paratekpharm.com